News | March 25, 2022
Parata Systems earns HITRUST certification
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
The first-of-its-kind unique centre will increase access to preventive & primary care
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
Pankaj Patel, Chairman, Zydus Lifesciences; Umang Vohra, CEO, Cipla; G V Prasad, Co-Chairman, Dr Reddy's; Nilesh Gupta, MD, Lupin and Dilip Shanghvi, MD, Sun Pharmaceuticals sharing their vision to outline the roadmap for the industry.
Clinical trial supply company strengthens its presence in the European Union
Tamper evident caps with incorporated RFID technology offer a significant reduction in RFID implementation costs
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
Subscribe To Our Newsletter & Stay Updated
